Nature Reviews Urology

Papers
(The median citation count of Nature Reviews Urology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
CDH12-expressing cell population predicts patient response to therapy145
Krause corpuscles act as genital vibration detectors130
Exploratory results from the CheckMate 214 trial121
Immune infiltration associated with outcomes113
Semen quality recovery following COVID-19112
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything85
Texture analysis for patient selection78
Single-cell and spatial sequencing of kidney cancer68
Human-relevant urothelial model provides insight into infection strategies and host response67
Sexual recovery interventions following prostate cancer treatment60
Time for women-centred gynaecology55
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer52
High-dose chemotherapy for relapsed testicular germ cell tumours52
Preclinical models of bladder cancer: BBN and beyond52
RAL-P in infants: expert tips for success52
PARP inhibitors plus enzalutamide to treat mCRPC50
Urine microbiota differ in bladder cancer50
Considering urology in a planetary context47
Advancing the state of the art in congenital obstructive uropathy47
The potential of CAR T cell therapy for prostate cancer46
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery45
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer45
A clinical guide to rare male sexual disorders45
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity44
FOXA2–KIT-driven lineage plasticity in NEPC42
Proteomic-based analysis of testicular interstitial fluid42
Prevalence of gender dysphoria in Japan41
A new text message-based platform for self-management of patients with IC/BPS40
Microfluidic sperm selection40
Evolution of the World Health Organization semen analysis manual: where are we?39
Ibrexafungerp to treat acute vulvovaginal candidiasis38
Galectins as potential therapeutic targets in STIs in the female genital tract37
Madrid plays host to a celebration of urology37
Metaverse in surgery — origins and future potential36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?35
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers34
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations34
Reducing the stigma of academic mental health can save lives34
What happens in Vegas … shapes the future of urology33
Overcoming antibiotic resistance in complicated UTI33
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer32
A non-invasive assay for UTUC diagnosis32
Resolving the puzzle of same-sex sexual interactions31
Pembrolizumab + axitinib beyond first-line therapy for mRCC31
Mirabegron safe and effective for NDO31
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence30
Measuring and improving the cradle-to-grave environmental performance of urological procedures30
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment29
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology28
Vaccination to prevent untreatable gonorrhoea27
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications27
COVID can’t kill CopMich collaboration27
177Lu–PSMA-PET extends survival27
The mechanism of action of neuromodulation in the treatment of overactive bladder27
Personalized 3D models for prostate cancer surgery26
Efficacy of the Revi system in treating urgency urinary incontinence26
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology25
PEACEing together prostate cancer therapy25
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway24
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?24
Effect of high glucose on E. coli24
Robots learning to imitate surgeons — challenges and possibilities24
Molecular events in neuroendocrine prostate cancer development24
Prostate cancer in transgender women — challenges in research and clinical care24
Is it time to rethink the current patient-reported outcome measures?24
Sexual orientation, gender identity and COVID: a complicated picture23
A clinical overview of people living with HIV and genitourinary cancer care22
Secondary kidney stones — remove or leave?22
AUA returns to its former glory in Chicago21
Cribriform morphology affects mpMRI imaging21
Successful mentorship for women in urology — a new era21
The magic of MagSToNE21
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC21
Women in urology: the past21
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease20
Promising efficacy of UTI vaccines as an alternative to antibiotics20
Microultrasonography-guided prostate cancer biopsy20
A distinct TAM subset mediates immunotherapy resistance in prostate cancer20
Videourodynamics — role, benefits and optimal practice20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards19
Current and emerging strategies to curb antibiotic-resistant urinary tract infections19
The placebo and nocebo effects in functional urology19
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer18
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer18
Androgen receptor pathway inhibitor combination in prostate cancer18
Metabolic response to immunotherapy in prostate cancer18
De-clear cell differentiated renal cell carcinoma — a new therapeutic target17
Management and cost of stent encrustation in pregnancy16
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer16
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer15
Turning up the heat: CTLA4 blockade in urothelial cancer14
Immune-based therapies in penile cancer14
The evolving treatment landscape of metastatic urothelial cancer14
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD13
Pride, not prejudice12
The prognostic role of stroma in UTUC11
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective11
The future of patient-derived xenografts in prostate cancer research11
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancer10
The shifting treatment paradigm of metastatic renal cell carcinoma10
The value of women urologists — individual and institutional imperatives to address salary equity10
The unclear role of PET–CT in localized radiorecurrent prostate cancer10
Hallmark discoveries in the biology of Wilms tumour10
We all get erections — de-gendering sexual arousal dysfunction in the ICD10
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself10
Prostate cancer screening: a new way forward or another false start?10
Uncovering a link between COVID-19 and renal cell carcinoma10
Mitomycin C plus cytosine arabinoside for NMIBC9
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer9
BAUSing back in Birmingham9
Improved phenotypic classification of male infertility to promote discovery of genetic causes9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome9
Understanding iGCA8
Patient selection is key in IMbassador2508
Effects of COVID-19 vaccine on semen parameters8
Tuft cells in prostate cancer8
CMA mediates resistance to androgen inhibitors in prostate cancer8
Men hold the balance of power8
Power up to investigate PrEP8
Mellow yellow: BilR reduces bilirubin to urobilinogen7
Microbiota manipulation to prevent oxalate kidney stone formation7
Spatiotemporal trends in human semen quality7
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer7
Diagnosis of ccRCC7
Male infertility and somatic health — insights into lipid damage as a mechanistic link7
Semen parameters across testicular cancer stages7
Metabolism, mitochondria and metastasis in kidney cancer7
Salvage therapy for prostate cancer after radical prostatectomy7
Mechanisms of the intestinal and urinary microbiome in kidney stone disease7
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI6
MRI diagnosis and radical prostatectomy outcomes6
Practical considerations for prostate hypofractionation in the developing world6
Mechanisms of the Supra-T paradox6
The ins and outs of penile erection6
Sperm activity affected by endometriosis6
Genetic ancestry and racial differences in prostate tumours6
Pronouns in English: a user’s guide6
Prostate luminal progenitor cells: from mouse to human, from health to disease5
Syphilis on the rise — a need for alternative therapies and vaccines5
Testosterone replacement therapy and spermatogenesis in reproductive age men5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference5
Artificial intelligence in the management of prostate cancer5
Particulate matter leaves a bitter taste in testes5
Advances in sliding clip renorrhaphy for partial nephrectomy5
Stepping up to prevent bacterial vaginosis recurrence5
Toilet-based continuous health monitoring using urine5
Influence of substance use on male reproductive health and offspring outcomes5
Genetic and biological drivers of prostate cancer disparities in Black men5
Chlorination by-products in drinking water — association with bladder cancer risk5
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS5
Probiotics to treat chronic bacterial prostatitis5
Clinical trial design for non-muscle-invasive bladder cancer5
Urology on a changing planet: links between climate change and urological disease5
The future of pelvic lymph node dissection for urological malignancies4
Author Correction: Advances in sperm analysis: techniques, discoveries and applications4
ADT intensification to treat biochemically recurrent prostate cancer4
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects4
Improving care for transgender and non-binary individuals4
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma4
The effects of diet on prostate cancer outcomes4
Being a non-native English speaker in science and medicine4
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma4
Gut microbiome’s effect on immunotherapy response4
Pregnancy and parental leave in medicine and academia — a focus on urology4
Feasibility and potential of an MRI-based prostate cancer screening4
The prostatic middle lobe: clinical significance, presentation and management4
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning4
Prescribing clinician specialty influences adherence to PrEP4
Landmarks in the evolution of prostate biopsy3
A vagina on a chip to model microbiome–host interactions3
Advancing perioperative care in MIBC: insights from NIAGARA3
Reply to ‘Management of very young fetuses with LUTO’3
A new surgical procedure to treat BPH3
Metastasis development in non-muscle-invasive bladder cancer3
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment3
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer3
Proteomic characterization of bladder cancer3
Prostate cancer epigenetics — from pathophysiology to clinical application3
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?3
Bone marrow microenvironment in prostate cancer3
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence3
The effect of red blood cell disorders on male fertility and reproductive health3
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research3
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications3
Urinary microbiota associated with OAB symptoms3
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury3
An app for optimizing UTI screening3
Clinical hypnosis improves LUTS3
New insights into APOBEC-mediated mutagenesis in prostate cancer3
Sex differences in bladder cancer: emerging data and call to action3
Sexual transfer of bacteria for forensic use3
Immunoliposome targeting IL-302
Metabolic flexibility in ccRCC2
Targeting TGCT2
Focusing on male infertility2
Abortion is a urology workforce issue2
Perspectives on chemsex2
Utility of PSA screening in transgender women receiving oestrogens2
Perspectives in primary hyperoxaluria — historical, current and future clinical interventions2
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC2
Bladder EpiCheck for NMIBC2
Generative AI in scientific publishing: disruptive or destructive?2
Human sperm RNA in male infertility2
Microplastics in the penis2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research2
Intravesical ICIs to reduce toxicity in NMIBC2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration2
20 years of ‘spilling the tea’ in urology2
The potential role of the microbiota in prostate cancer pathogenesis and treatment2
Islatravir implant as HIV-1 pre-exposure treatment2
Health-related quality of life after curative treatment for muscle-invasive bladder cancer2
Camrelizumab plus famitinib to treat RCC2
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care2
Metabolic alterations drive enzalutamide resistance2
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy2
Control of oncogenic signalling in ccRCC2
Robotic kidney transplantation2
Effects of the environment on the evolution of the vertebrate urinary tract2
NMIBC risk factors in patients treated with BCG2
Accessing information in the AI age2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer2
Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry2
Intestinal microbiota drive CRPC2
From foes to friends: rethinking the role of lymph nodes in prostate cancer2
Knockout of extended pelvic lymph node dissection during radical cystectomy2
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy2
UPEC-mediated alteration of host mitochondrial function — a survival strategy2
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease1
Home-based exercise for men with mCRPC1
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function1
The relationship between Black men with prostate cancer and their health-care providers1
AI in prostate MRI: enhancing accuracy and reducing overdiagnosis1
In-service training programmes to enhance surgical capacity in a resource-limited setting1
Interactions between androgen and IGF1 axes in prostate tumorigenesis1
Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes1
Embryonal origin of adult testicular macrophages1
Author Correction: Metaverse in surgery — origins and future potential1
Paternal microbiome perturbations affect offspring outcomes1
What is fuelling the monkeypox outbreak?1
Melon seed extract protects against testis metal toxicity1
First-morning urine samples to study the urobiome1
Artificial intelligence and urology: ethical considerations for urologists and patients1
Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome1
E-cigarettes and erectile dysfunction1
Cutting cholesterol curbs clear cell RCC1
Opening up about cancer and mental health1
A new signalling-based system for germ cell reprogramming1
Reply to ‘The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms — a paediatric urology perspective’1
0.18520903587341